Conexeu Sciences launches human collagen initiative for regenerative aesthetics as GLP-1 drives demand for tissue restoration
CNXU•Conexeu Sciences launched a human collagen initiative for regenerative aesthetics and continues to target a Q1 2027 FDA 510(k) submission for its CXU device.
1. Collagen initiative
Conexeu Sciences launched a human collagen initiative for regenerative aesthetics as GLP-1 drives demand for tissue restoration. The company continues to target a Q1 2027 FDA 510(k) submission for its CXU device.
